428 related articles for article (PubMed ID: 34498306)
1. Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016-1Q2021.
Chappuy M; Nourredine M; Clerc B; Fahmi M; Misslin P; Berthier M; Laloi L; Rolland B
Fundam Clin Pharmacol; 2022 Apr; 36(2):448-452. PubMed ID: 34498306
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
[TBL] [Abstract][Full Text] [Related]
3. The gabapentinoid drugs and their abuse potential.
Goins A; Patel K; Alles SRA
Pharmacol Ther; 2021 Nov; 227():107926. PubMed ID: 34171338
[TBL] [Abstract][Full Text] [Related]
4. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
[No Abstract] [Full Text] [Related]
5. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
6. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
Evoy KE; Covvey JR; Peckham AM; Reveles KR
Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188
[TBL] [Abstract][Full Text] [Related]
7. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
[TBL] [Abstract][Full Text] [Related]
8. Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017.
Vold JH; Skurtveit S; Aas C; Chalabianloo F; Kloster PS; Johansson KA; Fadnes LT
BMC Health Serv Res; 2020 Apr; 20(1):352. PubMed ID: 32334602
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin and pregabalin: do the benefits outweigh the harms?
Morrison EE; Sandilands EA; Webb DJ
J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
[TBL] [Abstract][Full Text] [Related]
10. Fatalities associated with gabapentinoids in England (2004-2020).
Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
[TBL] [Abstract][Full Text] [Related]
11. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
Chiappini S; Schifano F
CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
[TBL] [Abstract][Full Text] [Related]
12. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
Evoy KE; Peckham AM; Covvey JR; Tidgewell KJ
J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S89-S99. PubMed ID: 34396549
[TBL] [Abstract][Full Text] [Related]
13. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin and gabapentin in non-opioid poisoning deaths.
Kriikku P; Ojanperä I
Forensic Sci Int; 2021 Jul; 324():110830. PubMed ID: 34000615
[TBL] [Abstract][Full Text] [Related]
15. Abuse and Misuse of Pregabalin and Gabapentin.
Evoy KE; Morrison MD; Saklad SR
Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
[TBL] [Abstract][Full Text] [Related]
16. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings.
Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA
Addiction; 2019 Jun; 114(6):1026-1034. PubMed ID: 30098227
[TBL] [Abstract][Full Text] [Related]
17. Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017.
Rahman A; Kane J; Montastruc F; Renoux C
Br J Clin Pharmacol; 2021 Aug; 87(8):3349-3353. PubMed ID: 33393673
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery.
Liu B; Liu R; Wang L
Medicine (Baltimore); 2017 Sep; 96(37):e8031. PubMed ID: 28906391
[TBL] [Abstract][Full Text] [Related]
19. Gabapentinoid and Opioid Utilization and Cost Trends Among Injured Workers.
Liu C; Lavin RA; Yuspeh L; Leung N; Kalia N; Tsourmas NF; Williams L; Bernacki EJ; Tao XG
J Occup Environ Med; 2021 Feb; 63(2):e46-e52. PubMed ID: 33196519
[TBL] [Abstract][Full Text] [Related]
20. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
Tu TG; Sadeghi S; Atayee R; Lee K
Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
